PMC:7556165 / 25984-26388 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-sample-MedDRA

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T61","span":{"begin":55,"end":67},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T62","span":{"begin":134,"end":137},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T63","span":{"begin":186,"end":200},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A61","pred":"meddra_id","subj":"T61","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062026"},{"id":"A62","pred":"meddra_id","subj":"T62","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"},{"id":"A63","pred":"meddra_id","subj":"T63","obj":"http://purl.bioontology.org/ontology/MEDDRA/10002491"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sample-CHEBI

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T91","span":{"begin":186,"end":200},"obj":"Chemical"}],"attributes":[{"id":"A91","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A92","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_48432"},{"id":"A93","pred":"chebi_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/CHEBI_58506"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sample-PD-NCBITaxon

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T77","span":{"begin":303,"end":308},"obj":"Species"}],"attributes":[{"id":"A77","pred":"ncbi_taxonomy_id","subj":"T77","obj":"NCBItxid:10090"},{"id":"A78","pred":"ncbi_taxonomy_id","subj":"T77","obj":"NCBItxid:10088"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sample-sentences

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T166","span":{"begin":4,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sample-Pubtator

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"690","span":{"begin":18,"end":22},"obj":"Gene"},{"id":"691","span":{"begin":112,"end":116},"obj":"Gene"},{"id":"692","span":{"begin":134,"end":137},"obj":"Gene"},{"id":"693","span":{"begin":186,"end":200},"obj":"Gene"},{"id":"694","span":{"begin":235,"end":239},"obj":"Gene"},{"id":"695","span":{"begin":316,"end":320},"obj":"Gene"},{"id":"698","span":{"begin":303,"end":308},"obj":"Species"},{"id":"699","span":{"begin":283,"end":293},"obj":"Species"}],"attributes":[{"id":"A693","pred":"pubann:denotes","subj":"693","obj":"Gene:183"},{"id":"A692","pred":"pubann:denotes","subj":"692","obj":"Gene:1636"},{"id":"A691","pred":"pubann:denotes","subj":"691","obj":"Gene:59272"},{"id":"A698","pred":"pubann:denotes","subj":"698","obj":"Tax:10090"},{"id":"A690","pred":"pubann:denotes","subj":"690","obj":"Gene:59272"},{"id":"A699","pred":"pubann:denotes","subj":"699","obj":"Tax:10090"},{"id":"A695","pred":"pubann:denotes","subj":"695","obj":"Gene:70008"},{"id":"A694","pred":"pubann:denotes","subj":"694","obj":"Gene:70008"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sample-UniProt

LitCovid-sample-PD-GO-BP-0

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T66","span":{"begin":75,"end":85},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T67","span":{"begin":159,"end":175},"obj":"http://purl.obolibrary.org/obo/GO_0042310"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sample-GO-BP

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T68","span":{"begin":75,"end":85},"obj":"http://purl.obolibrary.org/obo/GO_0065007"},{"id":"T69","span":{"begin":159,"end":175},"obj":"http://purl.obolibrary.org/obo/GO_0042310"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-PubTator

{"project":"LitCovid-PubTator","denotations":[{"id":"690","span":{"begin":18,"end":22},"obj":"Gene"},{"id":"691","span":{"begin":112,"end":116},"obj":"Gene"},{"id":"692","span":{"begin":134,"end":137},"obj":"Gene"},{"id":"693","span":{"begin":186,"end":200},"obj":"Gene"},{"id":"694","span":{"begin":235,"end":239},"obj":"Gene"},{"id":"695","span":{"begin":316,"end":320},"obj":"Gene"},{"id":"698","span":{"begin":303,"end":308},"obj":"Species"},{"id":"699","span":{"begin":283,"end":293},"obj":"Species"}],"attributes":[{"id":"A690","pred":"tao:has_database_id","subj":"690","obj":"Gene:59272"},{"id":"A691","pred":"tao:has_database_id","subj":"691","obj":"Gene:59272"},{"id":"A692","pred":"tao:has_database_id","subj":"692","obj":"Gene:1636"},{"id":"A693","pred":"tao:has_database_id","subj":"693","obj":"Gene:183"},{"id":"A694","pred":"tao:has_database_id","subj":"694","obj":"Gene:70008"},{"id":"A695","pred":"tao:has_database_id","subj":"695","obj":"Gene:70008"},{"id":"A698","pred":"tao:has_database_id","subj":"698","obj":"Tax:10090"},{"id":"A699","pred":"tao:has_database_id","subj":"699","obj":"Tax:10090"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T166","span":{"begin":4,"end":210},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"5). The effect of ACE2 which has been more extensively investigated is the regulation of the RAAS system, where ACE2 counter-balances ACE, limiting the potent vasoconstrictive effect of angiotensin II (Ang-II). The first evidence that ACE2 was involved in RAAS control came from the transgenic knockout mouse model (ACE2–/–), which was characterized by severe reduction of cardiac contractility and thinn"}

PMC:7556165 / 25984-26388 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:7556165 / 25984-26388 JSON TXT